Company intelligence / Profile preview
ReiThera
Rome/Castel Romano Technopole, Lazio, Italyreithera.com ↗
- Ownership
- Private
- Employees
- ~100
- Development stage
- Other
01
Overview
ReiThera has a strong track record in developing genetic vaccines against major infectious diseases using innovative chimpanzee-derived adenoviral vectors. The company’s proprietary GRAd technology has been validated in human clinical trials. They have produced over eighty GMP lots in recent years and delivered the first ChAd3 Ebola Sudan vaccine doses to WHO during an outbreak response before Merck or Oxford/Jenner Institute. Their COVID vaccine candidate advanced into late-stage clinical development but did not reach commercialization due to regulatory decisions. The company now focuses both on its own advanced therapies pipeline and providing end-to-end CDMO services for third parties.
- Therapeutic areas
- OncologyNeurologyInfectious Diseases
- Modalities
- VaccineGene therapyViral vector-based therapyBiologic
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
MAGIC Consortium for muscular dystrophy researchWHO/Ebola responseMultiple pharmaceutical & biotech companies as clientsPreviously partnered with GSK post-acquisition of Okairos brand
Beyond the preview
Go deeper on ReiThera.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ReiThera.